Panbela Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Panbela Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Panbela Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$7K, a 75% decline year-over-year.
  • Panbela Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $983K, a 1265% increase year-over-year.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $198K.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$956K, a 56% decline from 2021.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$613K, a 189% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $198K +$1.15M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$956K -$343K -56% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$613K -$1.3M -189% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $691K +$2.98M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$2.29M -$25K -1.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$2.27M +$2.63M +53.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 -$4.89M -$4.61M -1617% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 -$285K -$46K -19.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$239K -$45K -23.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$194K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.